PB1867: ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – REAL-LIFE EXPERIENCE IN THE REDEFINITION OF EUROPEAN LEUKEMIANET RISK CLASSIFICATION

PB1867: ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – REAL-LIFE EXPERIENCE IN THE REDEFINITION OF EUROPEAN LEUKEMIANET RISK CLASSIFICATION

Bibliographic Details
Main Authors:	Rita S Gomes, Pedro Amorim Machado, Adriana Roque, Margarida Coucelo, Teresa Simões, Ana Oliveira, Telma Nascimento, Sandra Marini, Marta Pereira, Emilia Cortesão
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000974304.27403.8a

Similar Items

PB1880: ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – A DIFFERENT ENTITY IN THE ELDERLY?
by: Rita S Gomes, et al.
Published: (2023-08-01)

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
by: Ga-Young Song, et al.
Published: (2024-04-01)

The European LeukemiaNet: achievements and perspectives
by: Rüdiger Hehlmann, et al.
Published: (2011-01-01)

PB1847: ACUTE MYELOID LEUKEMIA – IS IT MORE BESIDES GENETIC ABNORMALITIES?
by: M. Urbano, et al.
Published: (2022-06-01)

PB1792: NGS VS PCR FOR THE DETECTION OF NPM1 GENE MUTATIONS IN ACUTE MYELOID LEUKEMIA.
by: N. Severina, et al.
Published: (2022-06-01)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
by: Maximiliano Cloobs Venezia, et al.
Published: (2022-11-01)

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
by: Mihee Kim, et al.
Published: (2024-12-01)

PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS
by: Christos Varelas, et al.
Published: (2023-08-01)

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: Marius Bill, et al.
Published: (2023-08-01)

Prognostic value of European LeukemiaNet 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia
by: Silvia Park, et al.
Published: (2023-09-01)

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features
by: Marlise R. Luskin, et al.
Published: (2015-10-01)

Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
by: Benedetta Mariotti, et al.
Published: (2019-01-01)

The discovery of <i>NPM1</i> mutations in acute myeloid leukemia
by: Paolo Sportoletti
Published: (2020-06-01)

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
by: Susanne Hirsch, et al.
Published: (2017-12-01)

Acute myeloid leukemia with concurrent NPM1 and RUNX1 mutations
by: Zhuang Zuo, et al.
Published: (2023-01-01)

Identification of a novel NPM1 mutation in acute myeloid leukemia
by: Yiyi Yao, et al.
Published: (2023-10-01)

NPM1 GENETIC VARIANTS: THE IMPORTANCE IN THE DIAGNOSIS OF THE ACUTE MYELOID LEUKEMIA
Published: (2023-10-01)

Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia
by: Marius Bill, et al.
Published: (2020-03-01)

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET
by: Kai Wille, et al.
Published: (2023-05-01)

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
by: Jesse M. Tettero, et al.
Published: (2022-01-01)

Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability
by: Giovanna Meloni, et al.
Published: (2009-02-01)

Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia
by: Ulrike Bacher, et al.
Published: (2018-10-01)

Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias
by: Ugo Testa, et al.
Published: (2023-06-01)

Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker
by: Nasrin Alizad Ghandforoush, et al.
Published: (2016-06-01)

European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera
by: Douglas Tremblay, et al.
Published: (2022-06-01)

Potential value of immunogenic cell death related-genes in refining European leukemiaNet guidelines classification and predicting the immune infiltration landscape in acute myeloid leukemia
by: Changqing Jiao, et al.
Published: (2025-02-01)

Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification
by: Meir Wetzler, et al.
Published: (2014-02-01)

A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1–HAUS1
by: Paulo Vidal Campregher, et al.
Published: (2016-07-01)

Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells
by: Lorenzo Brunetti, et al.
Published: (2024-10-01)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
by: Shano Naseem, et al.
Published: (2021-01-01)

Correction Notice: Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
Published: (2022-03-01)

PATHOGENIC VARIANTS IN THE NPM1 GENE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN AMAZONAS STATE, BRAZIL
by: TCD Santos, et al.
Published: (2024-10-01)

PB1806: AZACITIDINE + VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, POTENTIAL CANDIDATES TO ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT – RESULTS FROM A HOSPITAL CENTER
by: C. Barros Lima, et al.
Published: (2022-06-01)

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)
by: Hanane Djamai, et al.
Published: (2021-11-01)

Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome
by: Emily F. Mason, et al.
Published: (2019-11-01)

Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help
by: Brunangelo Falini, et al.
Published: (2010-04-01)

Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution
by: Qing Wei, et al.
Published: (2024-04-01)

Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
by: Magda Zidan, et al.
Published: (2013-06-01)

Assessment of 2022 European LeukemiaNet risk classification system in real‐world cohort from China
by: Enbo Chen, et al.
Published: (2023-12-01)

IMMUNOPHENOTYPIC SIGNATURE OF LEUKEMIA ARREST STAGE IS ASSOCIATED WITH NPM1/FLT3 MUTATIONAL PROFILE AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA
by: AG Carvalho, et al.
Published: (2024-10-01)